Platelet-Derived Growth Factor: A Key Factor in the Pathogenesis of Graves' Ophthalmopathy and Potential Target for Treatment

Publisher： Karger

E-ISSN： 2235-0802|3|4|217-226

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.3, Iss.4, 2014-12, pp. : 217-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Stress, Nuclear Factor-κB Pathway and Current Smoking in Graves' Ophthalmopathy

By  

European Thyroid Journal, Vol. 2, Iss. 1, 2013-02 ,pp. : 69-70

Karger

Access to resources Recommend Favorite

Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency

By  

European Thyroid Journal, Vol. 4, Iss. 4, 2015-0 ,pp. : 222-225

Karger

Access to resources Recommend Favorite

Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2016-02 ,pp. : 50-56

Karger

Access to resources Recommend Favorite

Metabolic Functions of Liver-Derived (Endocrine) Insulin-Like Growth Factor I

By  

Hormone Research in Paediatrics, Vol. 55, Iss. 2, 2004-11 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

Steroid Myopathy: Pathogenesis and Effects of Growth Hormone and Insulin-Like Growth Factor-I Administration

By  

Hormone Research in Paediatrics, Vol. 56, Iss. 1, 2004-11 ,pp. : 24-28

Karger

Access to resources Recommend Favorite